- Home
- CARS vs EMBC Comparison
CARS vs EMBC Comparison
Compare CARS & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARS
- EMBC
- Stock Information
- Founded
- CARS 1998
- EMBC 1924
- Country
- CARS United States
- EMBC United States
- Employees
- CARS N/A
- EMBC N/A
- Industry
- CARS Motor Vehicles
- EMBC Medical/Dental Instruments
- Sector
- CARS Consumer Discretionary
- EMBC Health Care
- Exchange
- CARS Nasdaq
- EMBC Nasdaq
- Market Cap
- CARS 723.4M
- EMBC 726.8M
- IPO Year
- CARS 2017
- EMBC N/A
- Fundamental
- Price
- CARS $11.17
- EMBC $11.65
- Analyst Decision
- CARS Buy
- EMBC Hold
- Analyst Count
- CARS 5
- EMBC 3
- Target Price
- CARS $18.30
- EMBC $17.67
- AVG Volume (30 Days)
- CARS 854.7K
- EMBC 442.4K
- Earning Date
- CARS 05-08-2025
- EMBC 05-09-2025
- Dividend Yield
- CARS N/A
- EMBC 5.17%
- EPS Growth
- CARS N/A
- EMBC N/A
- EPS
- CARS 0.69
- EMBC 0.89
- Revenue
- CARS $718,000,000.00
- EMBC $1,079,500,000.00
- Revenue This Year
- CARS $5.36
- EMBC N/A
- Revenue Next Year
- CARS $4.28
- EMBC $0.99
- P/E Ratio
- CARS $16.22
- EMBC $13.00
- Revenue Growth
- CARS 2.24
- EMBC N/A
- 52 Week Low
- CARS $9.87
- EMBC $10.12
- 52 Week High
- CARS $21.24
- EMBC $21.48
- Technical
- Relative Strength Index (RSI)
- CARS 46.86
- EMBC 48.12
- Support Level
- CARS $9.56
- EMBC $11.69
- Resistance Level
- CARS $11.52
- EMBC $12.71
- Average True Range (ATR)
- CARS 0.47
- EMBC 0.60
- MACD
- CARS -0.02
- EMBC 0.07
- Stochastic Oscillator
- CARS 60.07
- EMBC 32.64
About CARS Cars.com Inc.
Cars.com Inc is an online destination for buying and selling new and used vehicles. It is an audience-driven technology company empowering the automotive industry. The company brands include Dealer Inspire, DealerRater, FUEL, Accu-Trade, PickupTrucks.com, CreditIQ, and NewCars.com., websites directed towards different consumer segments.
About EMBC Embecta Corp.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.